Stanford University

Showing 191-200 of 540 Results

• 

  Azusa Terasaki

  Postdoctoral Scholar, Pathology
  

  BioAzusa Terasaki, MD, PhD, is a Postdoctoral scholar in the Department of Pathology at Stanford University School of Medicine. Her research focuses on tumor immunology and cancer metabolism, with a particular interest in mitochondrial transfer between cancer and immune cells and its role in immune suppression and metastasis.
  Dr. Terasaki received her medical degree and PhD in Japan, where she completed her surgical training and is a board-certified surgeon with additional certifications as a breast specialist and in cancer therapy. During her clinical career, she developed a strong interest in translational research that bridges fundamental discoveries and patient care.
  Her current work investigates how cancer cells reprogram immune cells through organelle transfer, integrating imaging, flow cytometry, and multi-omic approaches to uncover novel mechanisms of tumor–immune interaction. Her goal is to identify new therapeutic targets and biomarkers to improve cancer treatment outcomes.

  • Contact Info

    azyu0713@stanford.edu

  • Other Names:

    Azusa Murayama Terasaki
• 

  Rika Terashima

  Affiliate, Med/Quantitative Sciences Unit
  
• 

  Itamar Terem

  Casual - Non-Exempt, Adult Neurology
  
• 

  Abdullah Sulieman Terkawi, MD, MS

  Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
  
• 

  Aslihan Terzi

  Member, Maternal & Child Health Research Institute (MCHRI)
  
• Ezra Tesfay

  Administrative Associate, Emergency Medicine
  
• Alayet Tesfaye

  Sr. HR Administrator, Medicine
  
• 

  Nahom Worku Teshager

  Affiliate, Medicine - Primary Care and Population Health
  
• 

  Ana Tesi-Rocha, MD

  Clinical Professor, Pediatric Neurology
  Clinical Professor (By courtesy), Pediatrics
  
• 

  Stefano Testa

  Instructor, Medicine - Oncology
  

  BioDr. Testa is a medical oncologist and physician-scientist specializing in cellular therapy and the care of patients with soft tissue and bone sarcomas. He earned his medical degree from the University of Naples Federico II in Naples, Italy. He subsequently moved to the United States and conducted research in the laboratory of Dr. Ronald Levy at Stanford University, where he studied intratumoral vaccination strategies and mRNA delivery platforms designed to target B cells and T cells in vivo. He completed his internal medicine residency at Stanford University, followed by a fellowship in hematology and oncology at Beth Israel Deaconess Medical Center. Dr. Testa’s research focuses on identifying targets for adoptive T-cell therapies in solid tumors, particularly soft tissue and bone sarcomas, and on novel synthetic biology approaches to enhance the effectiveness of T-cell therapies against solid tumors.